The letter of intent arrives. The buyer wants your practice and offers cash at close plus rollover equity in the new company. The total looks strong. Part of that total, though, stays tied up in a business you will no longer run. So what are you agreeing to?

Here is the short answer. Rollover equity can serve you well, but the structure, the partner, and your own goals decide whether it does. Private equity firms keep buying physician groups, dental practices, and specialty clinics, and almost every recapitalization private equity sponsors put on the table includes a rollover. You will likely face this decision, so it pays to understand it before you negotiate.

What Is Rollover Equity, and Why Do Buyers Ask for It?

What is rollover equity in plain terms? You take part of your sale proceeds and reinvest them in the entity that buys your practice. Most of the price comes to you in cash. The rest becomes ownership in the buyer’s platform.

In healthcare deals, an equity rollover usually falls between 10% and 40% of seller proceeds. Buyers want it for alignment. A physician who owns a piece of the platform has reasons to stay, recruit colleagues, and push for growth after close.

Rollover works differently from other deferred payments. An earnout pays you later if the practice hits set targets. A seller note is a loan the buyer repays on a schedule. Rollover equity promises you nothing. You get paid when the platform sells, and only as much as that sale supports.

How a Private Equity Recapitalization Changes Your Position

You stop being the owner and become a minority holder in a bigger company. The sponsor and the board now decide strategy, capital spending, and timing.

Where your shares sit matters; in corporate practice of medicine states, physicians keep ownership of the clinical entity while the sponsor owns a management services organization (MSO). Your rollover typically lands in a holding company above the MSO. Find out which entity issues your shares and which entity controls the cash flows.

Your day-to-day pay shifts as well. Most deals reset compensation below what you earned as owner, often to a base salary plus productivity. Your employment agreement sets your term and termination rights, and the noncompete can run for years. Read those documents next to the equity terms, not after.

Tax treatment is a real advantage. If your advisors structure the rollover correctly, you defer tax on the rolled portion until a later sale. Get the structure wrong, and you owe tax on money you never received in cash.

When Rollover Equity Can Work in Your Favor

The main draw is the second bite of the apple. Sponsors usually plan to sell within three to seven years. If the platform grows during that window, your rolled stake can pay out an amount close to your first check.

Here is an illustrative scenario. You sell your dental practice at a $10 million valuation and roll 30%. You walk away with $7 million in cash and $3 million in platform equity. Over five years, the sponsor acquires dozens of practices and sells the platform at a higher multiple. If equity value triples after debt, your stake reaches about $9 million. That result depends on disciplined execution, moderate leverage, and a healthy exit market.

Add-on acquisitions bring scale. Larger groups win better payer rates. Shared billing, HR, and purchasing cut per-location costs. And you stay involved without carrying the full operational and financial risk, because the sponsor funds the expansion.

What Risks Do Healthcare Sellers Often Underestimate?

Businessman shining light on 3D blueprint showing hidden business risks and compliance issues.
  • The distribution waterfall. Sponsors often hold preferred equity that collects a set return before common holders see anything. A modest exit can leave common units with very little.
  • Platform debt. Lenders collect first at exit. Heavy leverage eats into common equity value even while revenue climbs.
  • Dilution. New capital raises and management incentive pools shrink your percentage over time.
  • Reimbursement and regulatory shifts. Medicare cuts, payer contract changes, and closer review of healthcare deals all move platform value. You control none of them.
  • Liquidity and timing. You cannot sell rolled equity when you want. The sponsor picks the exit date.

Questions to Answer Before You Agree to Roll Equity

Inflection 360 marketing graphic with ascending blue growth chart and text about scaling healthcare operations from day one.

About the Buyer and the Plan

Look hard at the sponsor’s history with healthcare platforms. How did prior exits go, and how did physician partners fare? Call clinicians who rolled equity in earlier deals and ask what they would do differently. Then ask the sponsor for its growth thesis, expected hold period, and likely exit path. If the answers stay vague, treat that as a warning.

About Your Equity and Rights

  • Does the sponsor value your rollover on the same terms as its own investment, at the same price and in the same class?
  • Do you hold tag-along rights, and what drag-along terms let others force a sale? Will you receive regular financial information and a board seat or observer role?
  • What protections limit dilution and keep your say over staffing, scheduling, and treatment decisions?

About Your Personal Goals

Figure out how much cash you need now and how much you can wait for. Retirement plans, children’s tuition, and other family obligations should shape your rollover percentage. Then look at concentration risk. If the rollover makes up a large share of your net worth, review it with your wealth advisor as part of the full plan.

Rollover equity is more a bet on a partner than on a valuation. Its worth comes down to the terms you negotiate, how well you prepare, and how closely the deal fits what you want next. Get independent advice before you sign the letter of intent, since your leverage drops once exclusivity starts.

Know What Your Rollover Is Really Worth Before You Agree to It

A rollover can double your second payout or leave you holding illiquid units behind a preferred waterfall you never read. Inflection 360 has acquired healthcare practices, so we know how sponsors structure rollovers, price your rolled stake, and use governance terms to protect their return over yours. We model your rollover under realistic exit scenarios, stress-test dilution and platform debt, and flag the terms worth fighting for, working alongside your attorney and tax advisor.

You decide how much risk to carry, and we make sure you see the full picture before exclusivity starts. If a letter of intent is on your desk or on the way, get an independent review of your rollover terms from Inflection 360 before you sign.

Discover 10 Strategies Now To Sell Your Business For Maximum Value

You have Successfully Subscribed!